| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5aa1a7415cb97cc8df88e2c6dd550e37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d5b30fa6c76058e5353fcb276d57e6ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d0586c37ffefbe6294c4d304bc9f35e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8643d1fcf7589b445f0d25dfa9e33327
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be944a7839fc8cabe752928d03dafaa4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-10343 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-195 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-861
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-19 |
| filingDate |
1998-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0a589b2be0cb809739006fb343d5be4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_010623f317d1f452d409e8ab997ef65d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42c51d335ca8ac0cd4b7dfcc7c4fd7e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_32dd9bba854252ac0119ee366e1ec4e2 |
| publicationDate |
1999-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9927122-A1 |
| titleOfInvention |
Vectors inhibiting or delaying the binding of an immunodeficiency virus to cells |
| abstract |
The invention concerns a recombinant viral vector in whose genome are inserted the sequences coding for at least a polypeptide for inhibiting or delaying the binding of an immunodeficiency virus to a target cell and/or the penetration of said virus into said cell, said viral vector not being an adenovirus vector in whose genome is inserted the DNAc coding for the murine RANTES. It also concerns an infectious viral particle, a host cell and a pharmaceutical composition comprising said vector, viral particle or host cell. It further concerns a method for preparing such an infectious viral particle. Finally, it concerns the therapeutic or prophylactic use of a viral vector, a viral particle, a host cell, an adenovirus vector expressing the murine RANTES and a plasmid vector comprising the sequences coding for at least a polypeptide for inhibiting or delaying the binding of an immunodeficiency virus to a target cell and/or the penetration of said virus into said cell, for preparing a medicine for the treatment immunodeficiency-related diseases using gene therapy. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6743594-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6740324-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6800729-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6511826-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6759519-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7025968-B2 |
| priorityDate |
1997-11-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |